{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:31:39Z","timestamp":1782167499233,"version":"3.54.5"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The initial presentations of childhood-onset primary Sj\u00f6gren\u2019s syndrome (C-pSS) vary, making diagnosis challenging. We aimed to improve the diagnosis and evaluation of C-pSS by summarizing its clinical and laboratory features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 49 patients with C-pSS between July 2015 and August 2022 in the Department of Rheumatology and Immunology of Shanghai Children's Medical Centre were enrolled in this study. Their clinical manifestations and laboratory examinations of these patients were compared based on the presence or absence of thrombocytopenia and parotitis and whether the immunological markers, including anti-nuclear antibodies (ANA), rheumatoid factor (RF), anti-Ro52\/SSA antibodies (anti-SSA\/Ro52), anti-Ro60\/SSA antibodies (anti-SSA\/Ro60), and anti-Ro\/SSB antibodies (anti-SSB), were positive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age at C-pSS diagnosis was 10.34\u2009\u00b1\u20093.45\u00a0years, and the ratio of boys to girls was 1:6. In the thrombocytopenia group, parotitis (<jats:italic>P\u2009<\/jats:italic>=\u20090.044), organ involvement except for hematology (<jats:italic>P\u2009<\/jats:italic>=\u20090.002), positive anti-SSB (<jats:italic>P\u2009<\/jats:italic>=\u20090.004), and positive RF (<jats:italic>P\u2009<\/jats:italic>=\u20090.001) were less frequently observed. Complement C4 (<jats:italic>P\u2009<\/jats:italic>=\u20090.038) and white blood cells (<jats:italic>P\u2009<\/jats:italic>=\u20090.002) levels decreased and increased significantly, respectively. Anti-SSB (<jats:italic>P\u2009<\/jats:italic>=\u20090.010) and RF (<jats:italic>P\u2009<\/jats:italic>=\u20090.004) positivity were independent potential protective factors against thrombocytopenia in patients with C-pSS. In the parotitis group, higher ANA titers (<jats:italic>P\u2009<\/jats:italic>=\u20090.027), higher focus scores on labial gland biopsy (<jats:italic>P\u2009<\/jats:italic>=\u20090.024), and positive RF (<jats:italic>P\u2009<\/jats:italic>=\u20090.001), anti-SSA\/Ro60 (<jats:italic>P\u2009<\/jats:italic>=\u20090.003), and anti-SSB (<jats:italic>P\u2009<\/jats:italic>=\u20090.001) were observed more frequently. Furthermore, positive anti-SSB (<jats:italic>P\u2009<\/jats:italic>=\u20090.012) and positive RF (<jats:italic>P\u2009<\/jats:italic>=\u20090.028) were independent risk factors for parotitis in patients with C-pSS. The hemoglobin level was significantly lower in patients with positive anti-SSA\/Ro52 and positive anti-SSA\/Ro60 results (<jats:italic>P\u2009<\/jats:italic>=\u20090.022 and <jats:italic>P\u2009<\/jats:italic>=\u20090.029, respectively), while immunoglobulin G level was significantly higher in patients in the same group (<jats:italic>P\u2009<\/jats:italic>=\u20090.048 and <jats:italic>P\u2009<\/jats:italic>=\u20090.007, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Positive anti-SSB and positive RF values may be independent potential protective factors of thrombocytopenia in patients with C-pSS. In contrast, positive anti-SSB and positive RF were independent risk factors of parotitis in patients with C-pSS. More studies are needed to reveal the diagnostic role and pathogenic mechanism of immunological markers in C-pSS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1044812","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:20:40Z","timestamp":1672849240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and laboratory features of childhood-onset primary Sj\u00f6gren's syndrome: A retrospective study from China"],"prefix":"10.3389","volume":"10","author":[{"given":"Chenxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanliang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/art.41676","article-title":"Sj\u00f6gren's disease, not syndrome","volume":"73","author":"Baer","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-med-043015-123313","article-title":"Mechanisms and new strategies for primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Mavragani","year":"2017","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sj\u00f6gren\u2019s syndrome-classification criteria and biomarkers","volume":"126","author":"Jonsson","year":"2018","journal-title":"Eur J Oral Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5152\/TurkPediatriArs.2016.2001","article-title":"Sj\u00f6gren\u2019s syndrome associated with systemic lupus erythematosus","volume":"51","author":"Ta\u015fdemir","year":"2016","journal-title":"Turk Arch Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/bmj.1.5120.466","article-title":"Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"1","author":"Heaton","year":"1959","journal-title":"Br Med J"},{"key":"B7","first-page":"343","article-title":"Features of childhood Sj\u00f6gren\u2019s syndrome in comparison to adult Sj\u00f6gren\u2019s syndrome: considerations in establishing child-specific diagnostic criteria","volume":"34","author":"Yokogawa","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.rdc.2008.08.009","article-title":"Relationship of Sj\u00f6gren\u2019s syndrome to other connective tissue and autoimmune disorders","volume":"34","author":"Theander","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1093\/rheumatology\/keab032","article-title":"Childhood-onset of primary Sj\u00f6gren\u2019s syndrome: phenotypic characterization at diagnosis of 158 children","volume":"60","author":"Ramos-Casals","year":"2021","journal-title":"Rheumatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/rheumatology\/keaa757","article-title":"Childhood Sj\u00f6gren syndrome: features of an international cohort and application of the 2016 ACR\/EULAR classification criteria","volume":"60","author":"Basiaga","year":"2021","journal-title":"Rheumatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.26442\/00403660.2019.05.000189","article-title":"Sj\u00f6gren\u2019s syndrome with juvenile onset","volume":"91","author":"Kaleda","year":"2019","journal-title":"Ter Arkh"},{"key":"B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.semarthrit.2020.11.004","article-title":"Childhood Sjogren\u2019s syndrome: an Italian case series and a literature review-based cohort","volume":"51","author":"Marino","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B15","first-page":"381","article-title":"Primary Sj\u00f6gren\u2019s syndrome in children and adolescents: proposal for diagnostic criteria","volume":"17","author":"Bart\u016fnkov\u00e1","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"B16","first-page":"2225","article-title":"Primary Sj\u00f6gren\u2019s syndrome in children and adolescents: are proposed diagnostic criteria applicable?","volume":"32","author":"Houghton","year":"2005","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"151945","DOI":"10.1016\/j.semarthrit.2021.11.011","article-title":"Recurrent or persistent salivary gland enlargement in children: when is it Sj\u00f6gren\u2019s?","volume":"52","author":"Pomorska","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/14397595.2018.1438093","article-title":"Clinical practice guideline for Sj\u00f6gren\u2019s syndrome 2017","volume":"28","author":"Sumida","year":"2018","journal-title":"Mod Rheumatol"},{"key":"B19","first-page":"540","article-title":"Usefulness of magnetic resonance sialography in patients with juvenile Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Tomiita","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/acr.23839","article-title":"Juvenile Sj\u00f6gren\u2019s syndrome: clinical characteristics with focus on salivary gland ultrasonography","volume":"72","author":"Hammenfors","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12969-020-00437-6","article-title":"Salivary gland ultrasound in the diagnostic workup of juvenile Sj\u00f6gren\u2019s syndrome and mixed connective tissue disease","volume":"18","author":"Krumrey-Langkammerer","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"B22","first-page":"76","article-title":"Salivary gland ultrasound findings are associated with clinical and serologic features in primary Sj\u00f6gren\u2019s syndrome patients. Salivary gland ultrasound findings are associated with clinical and serologic features in primary Sj\u00f6gren\u2019s syndrome patients","volume":"45","author":"Silva","year":"2020","journal-title":"Acta Rheumatol Port"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8hgmjm","article-title":"Factors associated with secondary immune thrombocytopenia in patients with primary Sj\u00f6gren\u2019s syndrome: a retrospective study of 639 cases","author":"Luo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3899\/jrheum.150058","article-title":"Relation of autoimmune cytopenia to glandular and systemic manifestations in primary Sj\u00f6gren syndrome: analysis of 113 Korean patients","volume":"42","author":"Koh","year":"2015","journal-title":"J Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fmed.2020.00138","article-title":"Clinical characteristics of secondary immune thrombocytopenia associated with primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Dai","year":"2020","journal-title":"Front Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/atm-22-162","article-title":"Clinical and laboratory features of primary Sj\u00f6gren\u2019s syndrome complicated with mild to severe thrombocytopenia","volume":"10","author":"Wu","year":"2022","journal-title":"Ann Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.12659\/msm.895144","article-title":"Elevated plasma P-selectin autoantibodies in primary Sj\u00f6gren syndrome patients with thrombocytopenia","volume":"21","author":"Hu","year":"2015","journal-title":"Med Sci Monit"},{"key":"B28","doi-asserted-by":"publisher","first-page":"637659","DOI":"10.3389\/fimmu.2021.637659","article-title":"Activation of toll-like receptor 7 signaling pathway in primary Sj\u00f6gren\u2019s syndrome-associated thrombocytopenia","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/rth2.12388","article-title":"Serum complement levels in immune thrombocytopenia: characterization and relation to clinical features","volume":"4","author":"Cheloff","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"B32","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1365-2362.2010.02342.x","article-title":"Autoimmune response and target autoantigens in Sjogren\u2019s syndrome","volume":"40","author":"Routsias","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1097\/MD.0000000000000667","article-title":"Primary Sj\u00f6gren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e11003","DOI":"10.1097\/MD.0000000000011003","article-title":"Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sj\u00f6gren syndrome patients: a case-control study","volume":"97","author":"Gao","year":"2018","journal-title":"Medicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","article-title":"Lung involvement in patients with primary Sj\u00f6gren\u2019s syndrome: what are the predictors?","volume":"30","author":"Yazisiz","year":"2010","journal-title":"Rheumatol Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.59.9.709","article-title":"Ten year follow up of pulmonary function in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"59","author":"Davidson","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/25785826.2021.1919342","article-title":"Clinical manifestations in anti-Ro52\/SS-A antibody-seropositive patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Nakamura","year":"2021","journal-title":"Immunol Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1044812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:20:45Z","timestamp":1672849245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1044812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":39,"alternative-id":["10.3389\/fped.2022.1044812"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1044812","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1044812"}}